197 related articles for article (PubMed ID: 20625390)
1. Systemic inflammation in young adults is associated with abnormal lung function in middle age.
Kalhan R; Tran BT; Colangelo LA; Rosenberg SR; Liu K; Thyagarajan B; Jacobs DR; Smith LJ
PLoS One; 2010 Jul; 5(7):e11431. PubMed ID: 20625390
[TBL] [Abstract][Full Text] [Related]
2. Reduced lung function in patients with abdominal aortic aneurysm is associated with activation of inflammation and hemostasis, not smoking or cardiovascular disease.
Fowkes FG; Anandan CL; Lee AJ; Smith FB; Tzoulaki I; Rumley A; Powell JT; Lowe GD
J Vasc Surg; 2006 Mar; 43(3):474-80. PubMed ID: 16520158
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory markers and longitudinal lung function decline in the elderly.
Jiang R; Burke GL; Enright PL; Newman AB; Margolis HG; Cushman M; Tracy RP; Wang Y; Kronmal RA; Barr RG
Am J Epidemiol; 2008 Sep; 168(6):602-10. PubMed ID: 18687665
[TBL] [Abstract][Full Text] [Related]
4. The interactions between cigarette smoking and reduced lung function on systemic inflammation.
Gan WQ; Man SF; Sin DD
Chest; 2005 Feb; 127(2):558-64. PubMed ID: 15705996
[TBL] [Abstract][Full Text] [Related]
5. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.
Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F
Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627
[TBL] [Abstract][Full Text] [Related]
6. Plasma fibrinogen and lung function: the CARDIA Study.
Thyagarajan B; Jacobs DR; Apostol GG; Smith LJ; Lewis CE; Williams OD
Int J Epidemiol; 2006 Aug; 35(4):1001-8. PubMed ID: 16554379
[TBL] [Abstract][Full Text] [Related]
7. Lack of association of ischemic heart disease with COPD when taking into account classical cardiovascular risk factors.
Izquierdo JL; Martínez A; Guzmán E; de Lucas P; Rodríguez JM
Int J Chron Obstruct Pulmon Dis; 2010 Nov; 5():387-94. PubMed ID: 21103405
[TBL] [Abstract][Full Text] [Related]
8. CRP is associated with lung function decline in men but not women: a prospective study.
Ólafsdóttir IS; Gíslason T; Gudnason V; Benediktsdóttir B; Ólafsson Í; Aspelund T; Thjódleifsson B; Janson C
Respir Med; 2013 Jan; 107(1):91-7. PubMed ID: 23083841
[TBL] [Abstract][Full Text] [Related]
9. Metabolic syndrome, insulin resistance and systemic inflammation as risk factors for reduced lung function in Korean nonsmoking males.
Lim SY; Rhee EJ; Sung KC
J Korean Med Sci; 2010 Oct; 25(10):1480-6. PubMed ID: 20890430
[TBL] [Abstract][Full Text] [Related]
10. Smoking, Systemic Inflammation, and Airflow Limitation: A Mendelian Randomization Analysis of 98 085 Individuals From the General Population.
Çolak Y; Afzal S; Lange P; Nordestgaard BG
Nicotine Tob Res; 2019 Jul; 21(8):1036-1044. PubMed ID: 29688528
[TBL] [Abstract][Full Text] [Related]
11. Systemic inflammation and lung function: A longitudinal analysis.
Hancox RJ; Gray AR; Sears MR; Poulton R
Respir Med; 2016 Feb; 111():54-9. PubMed ID: 26733230
[TBL] [Abstract][Full Text] [Related]
12. Lung function as a risk factor for subarachnoid hemorrhage: a prospective cohort study.
Söderholm M; Zia E; Hedblad B; Engström G
Stroke; 2012 Oct; 43(10):2598-603. PubMed ID: 22871680
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
[TBL] [Abstract][Full Text] [Related]
14. [Characteristics of stable chronic obstructive pulmonary disease related to systemic inflammation].
Solanes I; Bolíbar I; Llauger MA; Medrano C; Peiró M; Fraga M; Pou MA; Giner J; Freixas M; Plaza V;
Med Clin (Barc); 2012 Oct; 139(10):430-6. PubMed ID: 22766062
[TBL] [Abstract][Full Text] [Related]
15. Systemic inflammation and reduced pulmonary function in chronic spinal cord injury.
Garshick E; Stolzmann KL; Gagnon DR; Morse LR; Brown R
PM R; 2011 May; 3(5):433-9. PubMed ID: 21570031
[TBL] [Abstract][Full Text] [Related]
16. FEV
Hart JE; Goldstein R; Walia P; Teylan M; Lazzari A; Tun CG; Garshick E
BMC Pulm Med; 2017 Aug; 17(1):113. PubMed ID: 28810847
[TBL] [Abstract][Full Text] [Related]
17. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis.
Gan WQ; Man SF; Senthilselvan A; Sin DD
Thorax; 2004 Jul; 59(7):574-80. PubMed ID: 15223864
[TBL] [Abstract][Full Text] [Related]
18. Using dynamics of forced expiration to identify COPD where conventional criteria for the FEV₁ /FVC ratio do not match.
Topalovic M; Exadaktylos V; Decramer M; Berckmans D; Troosters T; Janssens W
Respirology; 2015 Aug; 20(6):925-31. PubMed ID: 25880716
[TBL] [Abstract][Full Text] [Related]
19. No relationship between lung function and high-sensitive C-reactive protein in adolescence.
Nybo M; Hansen HS; Siersted HC; Rasmussen F
Clin Respir J; 2010 Oct; 4(4):230-6. PubMed ID: 20887346
[TBL] [Abstract][Full Text] [Related]
20. Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.
Fortis S; Comellas A; Make BJ; Hersh CP; Bodduluri S; Georgopoulos D; Kim V; Criner GJ; Dransfield MT; Bhatt SP;
Ann Am Thorac Soc; 2019 Jul; 16(7):826-835. PubMed ID: 30908927
[No Abstract] [Full Text] [Related]
[Next] [New Search]
